Insider Buying: Judges Scientific (LON:JDG) Insider Purchases £172.59 in Stock

Judges Scientific plc (LON:JDG) insider Bradley Leonard Ormsby acquired 3 shares of Judges Scientific stock in a transaction that occurred on Monday, January 5th. The shares were purchased at an average price of GBX 5,753 per share, for a total transaction of £172.59.

Bradley Leonard Ormsby also recently made the following trade(s):

• On Friday, December 5th, Bradley Leonard Ormsby bought 2 shares of Judges Scientific stock. The stock was purchased at an average price of GBX 5,985 per share, with a total value of £119.70.

Judges Scientific Stock Performance

Shares of JDG stock opened at GBX 5,700 on Friday. The business’s 50-day moving average price is GBX 5,467.10 and its 200-day moving average price is GBX 6,267.81. Judges Scientific plc has a 12 month low of GBX 4,400 and a 12 month high of GBX 9,120. The firm has a market capitalization of £379.11 million, a price-to-earnings ratio of 34.97, a PEG ratio of 0.56 and a beta of 0.83. The company has a current ratio of 1.97, a quick ratio of 0.65 and a debt-to-equity ratio of 70.79.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on JDG shares. Berenberg Bank reissued a “buy” rating and set a GBX 7,900 target price on shares of Judges Scientific in a report on Wednesday, November 26th. Shore Capital reiterated a “house stock” rating on shares of Judges Scientific in a report on Thursday, September 18th. Finally, Jefferies Financial Group reissued a “buy” rating and issued a GBX 7,380 price objective on shares of Judges Scientific in a research note on Tuesday, November 4th. Two investment analysts have rated the stock with a Buy rating, According to MarketBeat.com, Judges Scientific has a consensus rating of “Buy” and a consensus target price of GBX 7,640.

Trending Headlines about Judges Scientific

Here are the key news stories impacting Judges Scientific this week:

• Positive Sentiment: Multiple insiders (including David Cicurel, Bradley Ormsby, Tim Prestidge and Ian Wilcock) purchased small lots (3 shares each) at ~GBX 5,753 on Jan 5 — a signal of insider confidence but immaterial in size. MarketBeat Insider Trades
• Positive Sentiment: Brokers have reaffirmed constructive ratings (Jefferies and Berenberg reiterating buys with targets ~GBX 7,380–7,900; consensus target ~GBX 7,640), which supports upside vs. the current price. MarketBeat Analyst Notes
• Neutral Sentiment: Judges remains an acquisitive group focused on niche scientific-instrument businesses (23 subsidiaries) — a steady, long-term strategy but one that can make near-term performance dependent on acquisition timing and integration. Company Profile
• Negative Sentiment: Balance-sheet and liquidity metrics may worry investors: a high debt-to-equity (~70.8%) and a quick ratio below 1 (0.65) increase sensitivity to earnings volatility. Financial Metrics
• Negative Sentiment: Technical weakness: the share price sits below the 200‑day moving average (GBX 6,308) and near the 50‑day, which can prompt tactical selling; intraday volume above average suggests higher selling pressure today. Price & Volume Data

Judges Scientific Company Profile

Judges Scientific plc (AIM: JDG), is a group focused on acquiring and developing companies in the scientific instrument sector. The Group now consists of 23 businesses acquired since 2005.

The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, scientific research facilities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group has received five Queen’s Awards for innovation and export.

The Group’s companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins.

Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash.